XinBio key facts
- Manufacturer, provider and developer of medical devices designed for cell and gene therapy.
- Notable investors include Step Holdings, Suzhou Wujiang Venture Capital, Suzhou Trust, Zhongshan Health Base Group, Xinrui Venture Capital.
- Status: Privately Held (backing).
- ·Watch XinBio: the Monday email on marks, rounds and moves
XinBio funding rounds
No funding rounds for XinBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
XinBio investors
5 investors are on record for XinBio, including Step Holdings, Suzhou Wujiang Venture Capital, Suzhou Trust and Zhongshan Health Base Group.
About XinBio
Manufacturer, provider and developer of medical devices designed for cell and gene therapy. The company focuses on automated, customized and one-stop solutions for cell and gene therapy development, enabling clients with medical devices.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Employees
- 80
- Website
- xinxiebio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
XinBio doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.